Role of matrix metalloprotease-9 in hyperoxic injury in developing lung

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 295, Issue 4, 2008, Pages

  Chetty, Anne ^a   Cao, Gong Jie ^a   Severgnini, Mariano ^a   Simon, Amy ^a   Warburton, Rod ^a   Nielsen, Heber C ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Bronchopulmonary dysplasia; Elastin; Morphometry

Indexed keywords

COLLAGEN TYPE 1; ELASTIN; GELATINASE A; GELATINASE B; OXYGEN; TROPOELASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GAS EXCHANGE; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG COMPLIANCE; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG FUNCTION; LUNG INFLATION; MESENCHYME; MORBIDITY; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BODY WEIGHT; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; LUNG; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; ELASTIN; HYPEROXIA; LUNG; MATRIX METALLOPROTEINASE 9; MICE; PULMONARY ALVEOLI; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS;

EID: 56149100905     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00441.2007     Document Type: Article

References (49)

1. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, Bland RD. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 159: 945-958, 1999.
2. Alejandre-Alcazar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, Sevilla-Perez J, Wygrecka M, Eul B, Kobrich S, Hesse M, Schermuly RT, Seeger W, Eickelberg O, Morty RE. Hyperoxia modulates TGF-β/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292: L537-L549, 2007.
3. Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Bromme D, Weber E, Cataltepe S. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 173: 318-326, 2006.
4. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinovitch M, Shinwell ES, Dixit A. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 294: L3-L14, 2008.
5. Bruce MC, Bruce EN, Janiga K, Chetty A. Hyperoxic exposure of developing rat lung decreases tropoelastin mRNA levels that rebound postexposure. Am J Physiol Lung Cell Mol Physiol 265: L293-L300, 1993.
6. Bruce MC, Schuyler M, Martin R, Starcher B, Tomashefski JF Jr, Wedig K. Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia. Am Rev Respir Dis 146: 204-212, 1992.
7. Bruce MC. Developmental changes in tropoelastin mrna levels in rat lung: evaluation by in situ hybridization. Am J Respir Cell Mol Biol 5: 344-350, 1991.
8. Bruce MC, Lo PY. A morphometric quantitation of developmental changes in elastic fibers in rat lung parenchyma: variability with lung region and postnatal age. J Lab Clin Med 117: 226-233, 1991.
9. Buckley S, Driscoll B, Shi W, Anderson K, Warburton D. Migration and gelatinases in cultured fetal, adult, and hyperoxic alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 281: L427-L434, 2001.
10. Buckley S, Warburton D. Dynamics of metalloproteinase-2 and -9, TGF-β, and uPA activities during normoxic vs. hyperoxic alveolarization. Am J Physiol Lung Cell Mol Physiol 283: L747-L754, 2002.
11. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, Andersson S. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 108: 686-692, 2001.
12. Chen PS, Zhai WR, Zhou XM, Zhang JS, Zhang YE, Ling YQ, Gu YH. Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells. World J Gastroenterol 7: 647-651, 2001.
13. Chetty A, Andersson S, Lassus P, Nielsen HC. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol 37: 128-136, 2004.
14. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30: 179-184, 2006.
15. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax 37: 572-579, 1982.
16. Curley AE, Sweet DG, Thornton CM, O'Hara MD, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, Warner JA. Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol 188: 871-875, 2003.
17. Darby I, Skalli O, Gabbiani G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63: 21-29, 1990.
18. Devaskar UP, Taylor W, Govindrajan R, Malicdem M, Heyman S, deMello DE. Hyperoxia induces interstitial (type I) and increases type IV collagenase mRNA expression and increases type I and IV collagenolytic activity in newborn rat lung. Biol Neonate 66: 76-85, 1994.
19. Dik WA, van Kaam AH, Dekker T, Naber BA, Janssen DJ, Kroon AA, Zimmermann LJ, Versnel MA, Lutter R. Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol Neonate 89: 6-14, 2006.
20. Dunnett CW. A multiple comparison procedure for several treatments with a control. J Am Stat Assoc 50: 1096-1121, 1955.
21. Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, Ballard PL, Truog WE. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113: 1709-1714, 2004.
22. Foronjy RF, Nkyimbeng T, Wallace AM, Thankachen J, Okada Y, Lemaitre V, D'Armiento JM. The transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am J Physiol Lung Cell Mol Physiol 294: L1149-L1157, 2008.
23. Hislop AA, Wigglesworth JS, Desai R, Aber V. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 15: 147-164, 1987.
24. Hosford GE, Fang X, Olson DM. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization. Pediatr Res 56: 26-34, 2004.
25. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
26. Infeld MD. Cell-matrix interactions in gland development in the lung. Exp Lung Res 23: 161-169, 1997.
27. Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, Mishima M. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 172: 1378-1382, 2005.
28. Jobe AJ. The new BPD: an arrest in lung development. Pediatr Res 46: 641-643, 1999.
29. Kraling BM, Wiederschain DG, Boehm T, Rehn M, Mulliken JB, Moses MA. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro. J Cell Sci 112: 1599-1609, 1999.
30. Lian X, Qin Y, Hossain SA, Yang L, White A, Xu H, Shipley JM, Li T, Senior RM, Du H, Yan C. Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. J Immunol 174: 7250-7256, 2005.
31. McGowan SE, Holmes AJ, Smith J. Retinoic acid reverses the airway hyperresponsiveness but not the parenchymal defect that is associated with vitamin A deficiency. Am J Physiol Lung Cell Mol Physiol 286: L437-L444, 2004.
32. McGrath-Morrow SA, Stahl J. Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 25: 150-155, 2001.
33. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, Segura-Valdez L, Sznajder JI, Selman M. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 153: 833-844, 1998.
34. Radomski A, Sawicki G, Olson DM, Radomski MW. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 125: 1455-1462, 1998.
35. Ramadurai SM, Chen WY, Yerozolimsky GB, Zagami M, Dammann CE, Nielsen HC. Cell-specific and developmental expression of phospholipase C-gamma and diacylglycerol in fetal lung. Am J Physiol Lung Cell Mol Physiol 284: L808-L816, 2003.
36. Simeone-Penney MC, Severgnini M, Tu P, Homer RJ, Mariani TJ, Cohn L, Simon AR. Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma. J Immunol 178: 6191-6199, 2007.
37. Sweet DG, Curley AE, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, Warner JA. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr 93: 791-796, 2004.
38. Tambunting F, Beharry KD, Hartleroad J, Waltzman J, Stavitsky Y, Modanlou HD. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia. Pediatr Pulmonol 39: 5-14, 2005.
39. Thibeault DW, Mabry SM, Ekekezie II, Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 106: 1452-1459, 2000.
40. Tomioka S, Bates JH, Irvin CG. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol 93: 263-270, 2002.
41. Torday JS, Rehan VK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res 62: 2-7, 2007.
42. Tortorolo L, Vento G, Matassa PG, Zecca E, Romagnoli C. Early changes of pulmonary mechanics to predict the severity of bronchopulmonary dysplasia in ventilated preterm infants. J Matern Fetal Neonatal Med 12: 332-337, 2002.
43. Toti P, Buonocore G, Tanganelli P, Catella AM, Palmeri ML, Vatti R, Seemayer TA. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol 24: 22-28, 1997.
44. Van Lierde S, Cornelis A, Devlieger H, Moerman P, Lauweryns J, Egermont E. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathological study. Biol Neonate 60: 152-162, 1991.
45. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, Elias JA. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31: 650-656, 2006.
46. Villanueva D, McCants D, Nielsen HC. Effects of epidermal growth factor (EGF) on the development of EGF-receptor (EGF-R) binding in fetal rabbit lung organ culture. Pediatr Pulmonol 29: 27-33, 2000.
47. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 275: L110-L117, 1998.
48. Wendel DP, Taylor DG, Albertine KH, Keating MT, Li DY. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol 23: 320-326, 2000.
49. Zhang XF, Ding SF, Gao YM, Liang Y, Foda HD. Expression of various matrix metalloproteinases in mice with hyperoxia-induced acute lung injury. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18: 449-451, 2006.